News & Sentiment
Restaurant Brands International Inc. Announces Renewal of Normal Course Issuer Bid
MIAMI, Sept. 11, 2026 /CNW/ -- Restaurant Brands International Inc. (TSX: QSR) (NYSE: QSR) ("RBI") announced today that it has filed, and the Toronto Stock Exchange (the "TSX") has accepted, notice of RBI's intention to renew its normal course issuer bid (the "NCIB") for its common shares....
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
430 articles
📰
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
Adma Biologics (ADMA) reached $9.23 at the closing of the latest trading day, reflecting a -1.7% change compared to its last close.
📰
UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, UnitedHealth Group (UNH) closed at $379.09, marking a -2.37% move from the previous day.
📰
Maze Therapeutics Chief Medical Officer Dumps Entire Direct Stake in the Company for $255,000
The executive liquidated his entire direct holdings as the stock plunged about 50% from its 52-week high.
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Liquidia's Yutrepia is gaining traction, but patent litigation, competition, rising costs and heavy product dependence cloud LQDA's outlook.
📰
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
Techne (TECH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰
Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰
Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
One company is scaling revenue rapidly but burning cash; the other is pioneering gene therapy with minimal sales and massive losses.
📰
Are Medical Stocks Lagging Amgen (AMGN) This Year?
Here is how Amgen (AMGN) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
📰
Are Medical Stocks Lagging Amgen (AMGN) This Year?
Here is how Amgen (AMGN) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?
Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?
Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?
Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?
Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.
📰
Amgen Drops 10% on a Trial It Didn't Even Run
AMGN stock fell after Novartis' Pelacarsen trial failed, though Amgen's own Olpasiran and Repatha differ in mechanism and results, and analysts have...
McKesson Corporation $MCK Shares Sold by Allworth Financial LP
Allworth Financial LP cut its stake in McKesson Corporation (NYSE:MCK – Free Report) by 14.2% during the second quarter, according to its most...
McKesson Corporation $MCK Shares Sold by Allworth Financial LP
Allworth Financial LP cut its stake in McKesson Corporation (NYSE:MCK – Free Report) by 14.2% during the second quarter, according to its most...
McKesson Corporation $MCK Shares Sold by Allworth Financial LP
Allworth Financial LP cut its stake in McKesson Corporation (NYSE:MCK – Free Report) by 14.2% during the second quarter, according to its most...
Bank of America Corp DE Sells 145,741 Shares of NeuroPace, Inc. $NPCE
Bank of America Corp DE reduced its stake in shares of NeuroPace, Inc. (NASDAQ:NPCE – Free Report) by 85.5% during the 1st quarter, according...
Bank of America Corp DE Reduces Stake in Enanta Pharmaceuticals, Inc. $ENTA
Bank of America Corp DE cut its stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 59.7% in the first quarter, according to...
Baird Financial Group Inc. Decreases Position in Illumina, Inc. $ILMN
Baird Financial Group Inc. lowered its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 14.6% in the 2nd quarter, according to its most...
Baird Financial Group Inc. Decreases Position in Illumina, Inc. $ILMN
Baird Financial Group Inc. lowered its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 14.6% in the 2nd quarter, according to its most...
Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA
Amundi lowered its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 1.8% during the 2nd quarter, according to the company in its most...
Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA
Amundi lowered its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 1.8% during the 2nd quarter, according to the company in its most...
Lone Peak Global Investors LLC Decreases Holdings in Johnson & Johnson $JNJ
Lone Peak Global Investors LLC decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 9.8% in the second quarter,...
Lone Peak Global Investors LLC Decreases Holdings in Johnson & Johnson $JNJ
Lone Peak Global Investors LLC decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 9.8% in the second quarter,...
Lone Peak Global Investors LLC Decreases Holdings in Johnson & Johnson $JNJ
Lone Peak Global Investors LLC decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 9.8% in the second quarter,...
Roche (OTCMKTS:RHHBY) Stock Passes Below 50-Day Moving Average – What’s Next?
Roche Holding AG (OTCMKTS:RHHBY – Get Free Report)’s share price crossed below its 50 day moving average during trading on Thursday . The...
Moleculin Biotech (NASDAQ:MBRX) Stock Crosses Below Fifty Day Moving Average – Time to Sell?
Moleculin Biotech, Inc. (NASDAQ:MBRX – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock...
Hsbc Holdings PLC Lowers Stock Holdings in PROCEPT BioRobotics Corporation $PRCT
Hsbc Holdings PLC trimmed its position in shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 52.6% during the second...
Hsbc Holdings PLC Lowers Stock Holdings in PROCEPT BioRobotics Corporation $PRCT
Hsbc Holdings PLC trimmed its position in shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT – Free Report) by 52.6% during the second...
Allworth Financial LP Cuts Stock Holdings in CVS Health Corporation $CVS
Allworth Financial LP reduced its stake in CVS Health Corporation (NYSE:CVS – Free Report) by 65.5% during the second quarter, according to the...